Fin Trust Capital Advisors, LLC Alkermes Plc. Transaction History

Fin Trust Capital Advisors, LLC

  • $577 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022
SELL
$22.0 - $31.87 $3,564 - $5,162
-162 Reduced 66.94%
80 $2,000
Q2 2022

Jul 26, 2022
SELL
$26.4 - $30.54 $4,620 - $5,344
-175 Reduced 41.97%
242 $7,000
Q1 2022

May 03, 2022
SELL
$23.07 - $27.99 $741,746 - $899,934
-32,152 Reduced 98.72%
417 $11,000
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $699,256 - $1.04 Million
32,569 New
32,569 $758,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email